Study type
|
Retrospective study
|
17 [22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38]
|
Prospective study
|
1 [39]
|
Biospecimen type
|
Serum
|
14 [22,23,24,25,26,27,28,29,30,31,32, 34, 35, 39]
|
Plasma
|
1 [33]
|
Serum and plasma
|
1 [36]
|
Serum and pleural effusion
|
1[37]
|
Serum and saliva
|
1 [38]
|
Storage temperature (°C)
|
− 80
|
9 [26,27,28,29,30, 32, 34, 35, 38]
|
− 20
|
6 [22,23,24,25, 37, 39]
|
− 70
|
1 [31]
|
− 85
|
1 [33]
|
− 20; − 70
|
1 [36]
|
Patient status/disease
|
Breast cancer
|
14 [22,23,24,25,26,27,28,29, 31,32,33,34,35, 38]
|
Pleural effusion
|
1 [37]
|
Adnexal masses and ovarian cancer
|
1 [30]
|
Pregnancy
|
1 [39]
|
Multiple disease
|
1 [36]
|
Measurement unit
|
U/mL
|
15 [22,23,24,25,26,27,28,29,30, 32,33,34, 36, 38, 39]
|
ng/mL
|
2 [35, 37]
|
U/L
|
1 [31]
|
Kit or instrument
|
CLEIA
|
4 [27, 28, 34, 35]
|
EIA
|
3 [25, 29, 39]
|
ELISA
|
3 [22, 37, 38]
|
HumaReader Plus made by HUMAN GmbH
|
2 [23, 24]
|
MEIA
|
2 [30, 31]
|
RIA
|
2 [26, 32]
|
CMIA
|
1 [33])
|
Vista vs Advia Centaur
|
1 [36]
|